StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note published on Monday. The brokerage issued a hold rating on the stock.
Retractable Technologies Stock Up 0.9 %
Shares of RVP stock opened at $0.90 on Monday. The company’s 50-day moving average is $1.01 and its 200 day moving average is $1.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. Retractable Technologies has a one year low of $0.87 and a one year high of $1.34.
Retractable Technologies (NYSE:RVP – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The company had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Further Reading
- Five stocks we like better than Retractable Technologies
- Basic Materials Stocks Investing
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Are Growth Stocks and Investing in Them
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- How to Calculate Stock Profit
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.